AUM
$2.0B
Estimated Dry Powder
$703.4M
Fund Size (Latest)
Not publicly reported
Estimated Cheque Size
$1.3M-$12.6M
Stages
- Seed
- Series A
- Series B
Fund Details
Year Established
1973
Website
https://www.abingworth.comHQ
1 St James's Market, London, SW1Y 4AH, UK, Europe
HQ Phone
+44 (0)20 7534 1500
About
Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs to develop ideas into products that have an impact on health. Abingworth invests at all stages of development, from start-ups to publicly traded companies, focused on pharmaceutical discovery and development and related enabling technologies. The firm operates out of offices in London, Menlo Park (California), and Boston. In August 2022, Abingworth was acquired by The Carlyle Group.
HQ Map
No mappable locations available.